News

Our Healthcare News

FDA Approves Cinqair to Treat Severe Asthma

FRAZER, Pennsylvania—The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in…  

Mar 23 2016

Elusys Therapeutics’ Anthrax Drug Gains FDA Approval in Adults and Children

PINE BROOK, New Jersey—Elusys Therapeutics Inc.’s injectable anthrax antitoxin, branded Anthim (obiltoxaximab), became the newest member of the elite club of drugs to gain FDA…  

Mar 21 2016

Molecular Partners Reveals Programs in Immuno-Oncology

Zurich-Schlieren, SWITZERLAND— Molecular Partners AG (ticker: MOLN), a clinical-stage biopharmaceutical company that is developing a powerful new class of therapies known as DARPins, today announced…  

Mar 07 2016

Baxalta and Symphogen Establish Strategic Collaboration to Accelerate Innovation in Immuno-Oncology

BANNOCKBURN, Ill. and COPENHAGEN, Denmark – Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and…  

Jan 04 2016

Ligand to Acquire OMT, Inc., a Leader in Human Antibody Generation, for $178 Million in Cash & Stock

SAN DIEGO & PALO ALTO, California—Ligand Pharmaceuticals Incorporated (NASDAQ:  LGND) and OMT, Inc. (Open Monoclonal Technology) announce the signing of agreements for Ligand to acquire…  

Dec 17 2015

Molecular Partners Received a European Small and Mid-Cap Award

ZURICH-SCHLIEREN, Switzerland—Molecular Partners AG (MOLN) announced today that the company has achieved a top 3 ranking in the category “Most Innovative Newcomer” at the Euro-pean…  

Dec 09 2015

Elusys Therapeutics Receives First Delivery Order from US Government for Anthim

PINE BROOK, New Jersey – Elusys Therapeutics, Inc. (Elusys) today announced it has been awarded its first delivery order under a procurement contract for Anthim…  

Nov 12 2015

Molecular Partners Wins European Biotechnica Award 2015

ZURICH, Switzerland—Molecular Partners AG (MOLN) announced today that it has been honored with the EUROPEAN BIOTECHNICA AWARD 2015. The award honors one company that has…  

Oct 07 2015